PeptidePub Blog

Research findings, pricing news, and vendor analysis across the peptide market.

Posts about Semaglutide

Showing 1 to 8 of 8

Pricing & Deals9 min read

What to Do If Your Employer Drops GLP-1 Coverage in 2026: Cash-Pay, Appeals, and Backup Programs

If your employer drops GLP-1 weight-loss coverage, first separate diabetes coverage from obesity coverage, then confirm denial reasons, appeal if documentation is missing, and compare brand self-pay or vetted telehealth cash-pay options. The fastest backup path is usually a reputable cash-pay program, but the safest choice depends on your drug, diagnosis, budget, and need for FDA-approved medication.

Read more →
Pricing & Deals9 min read

How to Use the Medicare GLP-1 Bridge on July 1: Eligibility, Prior Authorization, Pharmacy Steps, and Backup Options

The Medicare GLP-1 Bridge starts July 1, 2026 and can bring eligible obesity GLP-1 prescriptions to $50 per month, but only if the patient, indication, drug formulation, prior authorization, and pharmacy claim all line up. Use this checklist to prepare before launch and compare cash-pay backup options if the Bridge does not fit.

Read more →

STOP PIECING IT TOGETHER

One article at a time is a slow way to learn peptides.

We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.

Get the Handbook30-day money-back guarantee. Free updates for life.